Do you want to read an article? Please log in or register.
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study
Macular Diseases
Related content
Macular Diseases
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration
J Clin Med
Hatz K, Ambresin A, Schmid M, Prünte C, Barthelmes D, Machewitz T, Allmeier H, Somfai GM, XTEND Study Group
doi: 10.3390/jcm14072370
Macular Diseases
Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular Degeneration
Clin Exp Ophthalmol
Romano F, Casaluci M, Valastro A, Airaldi M, Milella P, Pozzo Giuffrida F, Cozzi E, Aretti A, Teo KY, Cheung CMG, Nassisi M, Viola F, Staurenghi G, Invernizzi A
doi: 10.1111/ceo.14608
Macular Diseases
Adherence to intravitreal aflibercept in neovascular age-related macular degeneration: 24-month results from the ANDROMEDA study
Ophthalmol Retina
Holz FG, Ziemssen F, Bauer Steinhusen U, Wachtlin J, Schürks M, Lorenz K, Scholz P, Machewitz T, Rech C, Lanzl I, Lommatzsch A, Finger RP, ANDROMEDA Study Group
doi: 10.1016/j.oret.2025.09.004
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular Diseases
Impact of Duration of Exposure to Intraretinal Fluid on Visual Outcomes in Neovascular Age-Related Macular Degeneration
Ophthalmol Retina
Steinle NC, McCullough AJ, Silva FQ, Du W, Moini H, Singh RP
doi: 10.1016/j.oret.2024.12.018
Macular Diseases
Photoreceptor layer thickness in age-related macular degeneration: the Beijing Eye Study
Br J Ophthalmol
Jonas JB, Panda-Jonas S, Pan Z, Wu X, Wang YX
doi: 10.1136/bjo-2024-326734
Macular Diseases
Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence
Sci Rep
Heinke A, Zhang H, Broniarek K, Michalska-Małecka K, Elsner W, Galang CMB, Deussen DN, Warter A, Kalaw F, Nagel I, Agnihotri A, Mehta NN, Klaas JE, Schmelter V, Kozak I, Baxter SL, Bartsch DU, Cheng L, An C, Nguyen T, Freeman WR
doi: 10.1038/s41598-024-78327-0
Macular Diseases
Treatment Regimens with Ranibizumab in Neovascular Age-Related Macular Degeneration: Real-World Results from the PACIFIC Study
Clin Ophthalmol
Lorenz K, Haritoglou C, Barthelmes D, Sefat AMM, Berk H, Beeke E, Scheffler M, Iwersen M, Müller B, Ziemssen F, members of the PACIFIC study group
doi: 10.2147/OPTH.S512630
Macular Diseases
Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Clin Exp Ophthalmol
Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA
doi: 10.1111/ceo.14559